Cargando…
To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial
AIM: The aim of the following study is to evaluate the efficacy and safety of Caralluma fimbriata extract (CFE) in overweight and obese individuals in a prospective, randomized, placebo controlled trial. MATERIALS AND METHODS: Commercially available CFE was assessed in overweight and obese individua...
Autores principales: | Arora, Ekta, Khajuria, Vijay, Tandon, Vishal R., Sharma, Atul, Mahajan, Annil, Gillani, Zahid H., Choudhary, Naiyma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314845/ https://www.ncbi.nlm.nih.gov/pubmed/25657901 http://dx.doi.org/10.4103/2229-3485.148812 |
Ejemplares similares
-
Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers
por: Choudhary, Naiyma, et al.
Publicado: (2014) -
Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
por: Arora, Ekta, et al.
Publicado: (2014) -
Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract
por: Kamalakkannan, Soundararajan, et al.
Publicado: (2010) -
Antihyperglycemic Activity of Caralluma fimbriata: An In vitro Approach
por: Ashwini, Shenai, et al.
Publicado: (2017) -
Angioedema due to fixed dose combination of telmisartan plus ramipril
por: Tandon, Vishal R., et al.
Publicado: (2014)